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Gliotoxin is a secondary metabolite of the epipolythiodioxopiperazine family with biologically active internal 
disulfide bridge. It is produced by many fungal species, including Aspergillus fumigatus and A. terreus. 
A. fumigatus, which produces gliotoxin and more than twenty other secondary metabolites, is the leading 
cause of invasive aspergillosis. Gliotoxin production in situ influence the development of aspergillosis. This 
study investigated the in vitro production of gliotoxin in nine A. fumigatus isolates from the upper respiratory 
tract of immunocompromised patients. The effects of media composition and incubation temperature 
were studied. Gliotoxin was extracted from biomass and its concentration was semi-quantitatively analysed 
using thin-layer chromatography. Gliotoxin production was higher in the yeast-extract liquid medium (YES) 
than in the synthetic Czapek-Dox liquid medium (CZA). Incubation at 37 °C resulted in higher gliotoxin 
production than at 25 °C, probably because higher temperatures favour expansive growth of the mycelium. 
Gliotoxin could be detected after three days of incubation at concentrations 4.06 mg mL-1 (in YES at 37 °C) 
and 1.07 mg mL-1 (in CZA at 25 °C). YES broth as a medium containing 4 % sucrose and 2 % of yeast 
extract is a very rich substrate for the production of gliotoxin in vitro.
KEY WORDS: aspergilosis, Czapek-Dox liquid medium, yeast-extracted liquid medium, 
toxicogenicity
Mycotoxin gliotoxin (Figure 1) is a secondary 
metabolite of many moulds: Aspergillus fumigatus, 
A. terreus, A. chevalieri, Penicillium terlikowskii, P. 
obscurum, P. cinerascens, Thermoascus crustaceus, 
Dichotomomyces cejpii, Trichoderma viride, 
Gliocladium fimbriatum, G. deliquescens and 
yeast Candida albicans (1-3). It is a member of 
epipolythiodioxopiperazine family with a biologically 
active disulfide bridge. There are some other toxins 
with active (poly)sulfide bridges such as sporidesmins, 
chetomins, and scabrosins, which also have biological 
effects on animals (4).
Because of very high incidence of invasive aspergil-
losis with high mortality among immunocompromised 
patients caused by saprophytic and thermophilic 
ubiquitous mould Aspergillus fumigatus Fresenius, 
the role of gliotoxin in the pathogenesis of aspergillosis 
has been a subject of many researchers (5, 6).
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Figure 1  Structure of gliotoxin (M=326.4)
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Gliotoxin has received attention over recent 
years because of its various biological effects, 
immunosuppression being the most studied. Gliotoxin 
also shows antimicrobial activity and leads to a drop 
in ciliary beating frequency, which is associated with 
epithelial damage. These effects help the spores of 
A. fumigatus to colonise the respiratory system (7). 
Gliotoxin inhibits phagocytosis and induces apoptosis 
in macrophages (8-10), thymocytes, spleen cells and 
cells of the mesenteric lymph nodes (11, 12). Gliotoxin 
inhibits T- and B-cell activation and proliferation, 
and inhibits the activity of alcohol dehydrogenase, 
reverse transcriptase, farnesyltransferase, and the 
transcription factor NFκB (13). It has been found 
in tissues infected with A. fumigatus: bovine udder 
(14), turkey lungs (15), mice lungs (16), in serum of 
patients with invasive aspergillosis (16), and in vaginal 
fluid of women with vaginitis caused by Candida 
albicans (3).
The ability to produce secondary metabolites in 
vitro is used to test the toxicity of fungal isolates. This 
can help to predict mycotoxin production in various 
substrates such as cereals, smoked meat or even 
in infected tissues or organs. Mycotoxin production 
depends on genetic properties of fungal strains, 
and on the substrate as a potential precursor in the 
biosynthesis of mycotoxins. The aim of this study was 
to compare in vitro gliotoxin production in two media 
formulations at two different temperatures.
MATERIAL AND METHODS
Fungi tested
Nine isolates of gliotoxin-producing strains of 
Aspergillus fumigatus were used to investigate the 
influence of medium and temperature on gliotoxin 
production. The strains were isolated from sputum 
(four), nose swab (two) or from tracheal aspirate (three) 
of immunocompromised patients from a haematology 
ward with the following underlying diseases: myeloid 
or lymphatic leukaemia (six), Hodgkin’s lymphoma 
(one), non-Hodgkin’s syndrome (one). One strain was 
isolated in a heart operation. Isolates were stored on 
2 % Sabouraud glucose agar (Merck, Germany) slants 
at +4 °C before analysis. At the time of analysis, nine 
isolates of A. fumigatus were grown on Sabouraud 
2 % (w/V) glucose agar slants for 3 days at (25±2) °C 
and the conidia were harvested with sterile saline with 
0.1 % polysorbate 80 (Tween® 80). The concentration 
of conidia was approximately 107 mL-1, estimated by 
inoculation of 100 μL of conidial suspension on the 
surface of 2 % Sabouraud glucose agar. One mL of 
conidial suspension was used for inoculation of 50 
mL of media for biosynthesis.
Biosynthesis
Two liquid media were used for biosynthesis: 
yeast-extract-sucrose broth (YES, composition: yeast 
extract 20 g, sucrose 40 g, distilled water 1000 mL, pH 
5.8±0.2) and Czapek-Dox broth (CZA, composition: 
MgSO4x7H2O 0.5 g, FeSO4 0.01 g, KCl 0.5 g, KH2PO4 
1 g, NaNO3 3 g, sucrose 30 g, distilled water 1000 mL, 
pH 7.3±0.2). Erlenmayer flasks (250 mL) were filled 
with 50 mL of media for biosynthesis and autoclaved 
for 15 minutes at 121 °C. After cooling at room 
temperature, broths were inoculated with conidial 
suspension and incubated at two temperatures: 
(25±2) °C and (37±1) °C. The incubation time was 3, 
6, 9, and 12 days. During the incubation, flasks were 
shaken manually at least twice a day.
All microbiological media and chemicals were 
purchased from Merck, Germany. All chemicals were 
of analytical grade.
Extraction and quantification of gliotoxin
After incubation time, the biomass was extracted 
with 50 mL of chloroform (Kemika, Croatia) and 
cut up in small pieces with electric homogeniser at 
3.500 rpm for 10 min. The biomass was then filtered 
through a Whatman No.1 filter paper and extracted 
using 2x25 mL of chloroform, and filtered through 
anhydrous Na2SO4 (Merck, Germany). Chloroform 
fraction was pooled and evaporated to dryness on 
rotary evaporator under reduced pressure at 60 °C. 
Dried extracts were dissolved in 500 µL chloroform 
and stored at +4 °C until gliotoxin was analysed. 
The detection and semi-quantitative analysis was 
performed using a method described by Bauer et al. 
(14). The concentration of gliotoxin in extracts was 
determined by comparing the fluorescence of gliotoxin 
from extracts and from standard solutions of known 
concentration (from 0.01 µg mL-1 to 0.5 µg mL-1) 
on thin-layer chromatography plates (TLC, silica gel 
GF254 with fluorescent indicator, thickness 0.25 mm, 
20x20 cm, Merck, Germany) under 366 nm. Before 
that, the plates were developed in mobile-phase 
toluene:ethyl acetate:formic acid (5:4:1), sprayed 
with 20 % AgNO3 in ethanol (96 %) and heated for 
10 minutes at 110 °C.
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The calibration curve for gliotoxin production was 
constructed in two different media. All chemicals and 
solvents were of analytical grade. 
Statistical analysis
The concentration of gliotoxin obtained from 
nine A. fumigatus isolates cultured for biosynthesis 
in the same medium and at the same temperature 
is expressed as mean ±SE. The concentration of 
gliotoxin from the YES broth was compared with the 
concentration from the CZA broth using the t-test 
non-parametric Mann-Whitney U post-test (GraphPad 
Software, USA). The level of significance was set as 
p<0.05.
RESULTS AND DISCUSSION
The effect of temperature and two liquid media 
formulations on the gliotoxin production of nine 
clinical isolates of A. fumigatus was tested in vitro. 
The results are shown in Figures 2 and 3.
Gliotoxin was detected after 3 days of incubation 
in the YES broth at both temperatures of (25±2) °C 
and (37±1) °C. Higher production was observed at 
(37±1) °C than at (25±2) °C, and higher temperature 
stimulated gliotoxin production during the experiment. 
After 12 days of incubation at (37±1) °C, the 
concentration of gliotoxin doubled compared to 
the concentration incubated at (25±2) °C. The 
concentration of gliotoxin in the same media 
increased progressively during incubation, the average 
being 4.06 mg mL-1 after 3 days, and 8.59 mg mL-1 
after 12 days. At (25±2) °C, the concentration of 
gliotoxin in the YES broth doubled more quickly than 
at (37±1) °C. The average concentration after 3 days 
was 1.07 mg mL-1 and after 6 days 2.22 mg mL-1. The 
concentration of gliotoxin was five times higher after 
12 days than after 3 days at the same temperature 
and in the same medium. As a medium containing 
4 % sucrose (source of carbon) and 2 % yeast extract 
(source of nitrogen), YES is a very rich substrate for in 
vitro production of gliotoxion, a lipophilic secondary 
metabolite of A. fumigatus.
The influence of a synthetic media Czapek- 
Dox broth, containing 3 % sucrose as a source of 
carbon and 0.3 % NaNO3 as a source of nitrogen, 
on gliotoxin production was also compared between 
two temperatures. After 3 days, gliotoxin production 
was higher at (37±1) °C than at (25±2) °C, and the 
concentrations increased after 6, 9 and 12 days. After 
12 days of incubation at (37±1) °C, the concentration 
of gliotoxin doubled with respect to the concentration 
at (25±2) °C, indicating that higher temperature 
better stimulated gliotoxin production in the synthetic 
Czapek-Dox broth. 
The concentration of gliotoxin, produced in 
different media formulations (YES and CZA), was 
compared with regard to the incubation temperature. 
Statistically significant differences in gliotoxin 
production were noted after 3, 6, 9, and 12 days in 
six strains of A. fumigatus on the YES and CZA broth 
at both temperatures, with a higher production in the 
YES broth (p<0.05). Our results indicate that in vitro 
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Figure 2  Gliotoxin production in the YES broth at different incubation 
temperatures
Figure 3  Gliotoxin production in the CZA broth at different incubation 
temperatures
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production of gliotoxin is higher in YES broth than in 
CZA broth, and that gliotoxin could be detected after 
only 3 days of incubation.
Our results were confirmed by an earlier study 
by Belkacemi et al. (17), who found that incubation 
at higher temperatures (37 °C vs. 10 °C, 20 °C, and 
30 °C) increased gliotoxin production.
As a thermophilic mould, A. fumigatus shows 
faster growth at higher temperatures, which is 
associated with greater gliotoxin production. We tested 
gliotoxin production in liquid media containing 4 % or 
3 % sucrose. The differences between the two media 
suggest that the yeast extract (2 %) with a greater 
amount of sucrose (4 %) better stimulates in vitro 
production of gliotoxin.
CONCLUSIONS
Gliotoxin is one of the mycotoxins produced by 
Aspergillus fumigatus, the most common mould 
isolate in the life-threatening invasive aspergillosis. 
It has many biological effects, immunosuppression 
being the most studied. In vitro production of 
mycotoxins is mediated by substrates as source of 
its precursors.
Our study shows that liquid media with 4 % 
sucrose and 2 % yeast extract (YES) at the incubation 
temperature of 37 °C are both suitable for rapid 
screening of A. fumigatus for gliotoxin production, 
because it takes no longer than three days to detect 
gliotoxin in these cultures. YES is a very rich medium 
for gliotoxin production, and after three days, the 
concentrations in the YES broth were 4.06 mg mL-1 
and 1.07 mg mL-1 at 37 °C and 25 °C, respectively. 
Gliotoxin is produced during mycelar growth of A. 
fumigatus.
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Sažetak
UTJECAJ MEDIJA I TEMPERATURE NA TVORBU GLIOTOKSINA U SOJEVA ASPERGILLUS 
FUMIGATUS
Gliotoksin je sekundarni metabolit iz skupine epipolitiodioksipiperazina s biološki aktivnim internim 
disulfidnim mostom u molekuli, koji tvore razne plijesni i gljivica Candida albicans.
Plijesan Aspergillus fumigatus vodeæi je uzroènik invazivnih aspergiloza i takoðer može tvoriti gliotoksin. 
Pretpostavlja se da in situ tvorba gliotoksina utjeèe na patogenezu aspergiloze.
U ovom radu ispitali smo in vitro tvorbu gliotoksina u devet sojeva A. fumigatus vrste, izoliranih iz 
imunokompromitiranih pacijenata. Praæen je utjecaj medija i temperature inkubacije na tvorbu gliotoksina. 
Gliotoksin je ekstrahiran iz biomase i koncentracija mu je utvrðena polukvantitativno tankoslojnom 
kromatografijom. Tvorba gliotoksina uoèena je veæ nakon trodnevne inkubacije u koncentracijama 4,06 
mg mL-1 (u bujonu s kvašèevim ekstraktom – YES na 37 °C) i 1,07 mg mL-1 (u sintetskom Czapek-Dox 
bujonu – CZA na 25 °C). Tvorba gliotoksina bila je veæa u YES bujonu, za razliku od sintetskog CZA bujona. 
Viša temperatura inkubacije (37 °C) takoðer utjeèe na jaèu tvorbu gliotoksina nego niža temperatura 
(25 °C).
YES bujon s dodatkom 4 % saharoze i 2 % kvašèeva ekstrakta vrlo je bogat supstrat za in vitro tvorbu 
gliotoksina, kao jednog od lipofilnih sekundardnih metabolita plijesni vrste A. fumigatus.
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